Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “C. Diff. Infections”

274 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 274 results

Large-scale testing (Phase 3)Ended earlyNCT02395848
What this trial is testing

Efficacy of 30-day Duration of Fidaxomicin for Recurrent C. Difficile Infection

Who this might be right for
Clostridium Difficile Infection
McMaster University 31
Not applicableStudy completedNCT01813500
What this trial is testing

Host Immune Response to Clostridium Difficile Infection in Inflammatory Bowel Disease Patients

Who this might be right for
Crohn's DiseaseUlcerative ColitisClostridium Difficile+1 more
Boston Medical Center 400
Testing effectiveness (Phase 2)WithdrawnNCT03643887
What this trial is testing

Phase II Trial of Fecal Microbiota Transplant (FMT) for VRE and CRE Patients

Who this might be right for
Clostridium Difficile Infection
University of Wisconsin, Madison
Large-scale testing (Phase 3)Study completedNCT04138706
What this trial is testing

Initial Vancomycin Taper for the Prevention of Recurrent Clostridium Difficile Infection

Who this might be right for
Clostridium Difficile Infection
McGill University Health Centre/Research Institute of the McGill University Health Centre 263
Not applicableStudy completedNCT06277999
What this trial is testing

C.Difficile Observational Study

Who this might be right for
Clostridium Infections
AstraZeneca 7
Post-approval studies (Phase 4)WithdrawnNCT05077085
What this trial is testing

Bezlotoxumab Versus FMT for Multiple Recurrent CDI

Who this might be right for
Clostridium InfectionsClostridioides DifficileEnterocolitis, Pseudomembranous
Leiden University Medical Center
Testing effectiveness (Phase 2)Study completedNCT01085591
What this trial is testing

Study of CB-183,315 in Participants With Clostridium Difficile Infection

Who this might be right for
Clostridium Difficile InfectionDiarrhea
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 210
Not applicableStudy completedNCT02327520
What this trial is testing

Clostridium Difficile Infection: the First Report in Southeast Asia by 2010 Nationwide Study

Who this might be right for
Clostridium Difficile Infection
King Chulalongkorn Memorial Hospital 204,666
Post-approval studies (Phase 4)Study completedNCT03388268
What this trial is testing

TOX NEG Trial: Clostridium Difficile Diagnosis and Treatment

Who this might be right for
Clostridium Difficile InfectionDiarrhea
Washington University School of Medicine 15
Not applicableLooking for participantsNCT04801862
What this trial is testing

Natural History of Clostridioides Difficile Infection

Who this might be right for
Clostridium Difficile InfectionHealth Care Associated InfectionNosocomial Infection
Hospital Universitario de Valme 750
Not applicableLooking for participantsNCT06788769
What this trial is testing

Study of Clostridioides Difficile in Infants

Who this might be right for
Clostridioides Difficile Infection
Westlake University 300
Post-approval studies (Phase 4)Ended earlyNCT01972932
What this trial is testing

Study of Bio-K+® in the Reduction of the Risk of Clostridium Difficile Infection and Antibiotic Associated Diarrhea

Who this might be right for
Clostridium Difficile InfectionAntibiotic Associated Diarrhea
Bio-K Plus International Inc. 60
Testing effectiveness (Phase 2)Study completedNCT05304715
What this trial is testing

Bezlotoxumab Yielded Outcomes by Addressing Personalized Needs in Clostridioides Difficile Infection

Who this might be right for
Clostridioides Difficile InfectionStool MicrobiomeOrgan Dysfunction Syndrome+2 more
Hellenic Institute for the Study of Sepsis 44
Not applicableStudy completedNCT03503474
What this trial is testing

COMBACTE-CDI Understanding the Burden of C. Difficile Infection

Who this might be right for
Clostridium Difficile Infection
University of Leeds 3,240
Large-scale testing (Phase 3)Study completedNCT03182907
What this trial is testing

Bezlotoxumab (MK-6072) Versus Placebo in Children With Clostridium Difficile Infection (CDI) (MK-6072-001)

Who this might be right for
Clostridium Difficile Infection
Merck Sharp & Dohme LLC 148
Not applicableTemporarily pausedNCT03350711
What this trial is testing

A Screening and Recruitment Study in Adults Expressing Interest in the Emory Microbiota Enrichment Program

Who this might be right for
Clostridium Difficile Infection
Emory University 200
Not applicableLooking for participantsNCT07250724
What this trial is testing

C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.

Who this might be right for
Clostridioides Difficile Infection Recurrence
Bactolife A/S 60
Early research (Phase 1)Study completedNCT01914731
What this trial is testing

Fecal Microbiota Transplant for Relapsing Clostridium Difficile Infection in Adults and Children Using a Frozen Encapsulated Inoculum

Who this might be right for
Clostridium Difficile Infection
Massachusetts General Hospital 20
Post-approval studies (Phase 4)Study completedNCT02467621
What this trial is testing

Stress Ulcer Prophylaxis in the Intensive Care Unit

Who this might be right for
Gastrointestinal BleedingStress Ulcers
Dr. Morten Hylander Møller 3,350
Testing effectiveness (Phase 2)Study completedNCT02299570
What this trial is testing

Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection

Who this might be right for
Enterocolitis Clostridium Difficile Recurrent
Rebiotix Inc. 150
Load More Results